Provided by Tiger Trade Technology Pte. Ltd.

Global Blood Therapeutics

68.49
0.0000
Volume:- -
Turnover:224.61M
Market Cap:4.62B
PE:-13.69
High:68.49
Open:68.49
Low:68.49
Close:68.49
52wk High:73.02
52wk Low:21.65
Shares:67.48M
Float Shares:58.58M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0019
EPS(LYR):-4.8138
ROE:-148.56%
ROA:-25.18%
PB:39.05
PE(LYR):-14.23

Loading ...

Jun 29, 2022

Major Issues Report

8-K - Current report
Jun 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 15, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
Jun 06, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2022

Major Issues Report

8-K - Current report
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 27, 2022

Major Issues Report

8-K - Current report